IL-22 mediates host defense against an intestinal intracellular parasite in the absence of IFN-γ at the cost of Th17-driven iImmunopathology

Journal of Immunology

Volumn 188, Issue 5, 2012, Pages 2410-2418

  Stange, Jörg ^a   Hepworth, Matthew R ^a   Rausch, Sebastian ^a   Zajic, Lara ^a   Kühl, Anja A ^b   Uyttenhove, Catherine ^c   Renauld, Jean Christophe ^c   Hartmann, Susanne ^a   Lucius, Richard ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GELATINASE B; INTERLEUKIN 17; INTERLEUKIN 22; POLYPEPTIDE ANTIBIOTIC AGENT; REGIIIBETA PROTEIN; REGIIIGAMMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EIMERIA FALCIFORMIS; FEMALE; HOST RESISTANCE; IMMUNOPATHOLOGY; IN VITRO STUDY; INTESTINAL INTRACELLULAR PARASITE; INTESTINE; INTESTINE PARASITE; MESENTERY LYMPH NODE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TH17 CELL; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; CECUM; CELL LINE; COCCIDIOSIS; COLON; EIMERIA; FEMALE; IMMUNITY, CELLULAR; INTERFERON-GAMMA; INTERLEUKINS; INTESTINAL DISEASES, PARASITIC; INTESTINAL MUCOSA; INTRACELLULAR FLUID; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, INTERFERON; SIGNAL TRANSDUCTION; TH17 CELLS;

EID: 84857493473     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102062     Document Type: Article

References (41)

1. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-g receptor. Science 259: 1742-1745. (Pubitemid 23114659)
2. + cells protect mice against reinfection with the intestinal parasite Eimeria falciformis. Microbes Infect. 12: 218-226.
3. Yap, G. S., and A. Sher. 1999. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-γ- and tumor necrosis factor (TNF)-α-dependent host resistance to the intracellular pathogen, Toxoplasma gondii. J. Exp. Med. 189: 1083-1092.
4. McCall, M. B. B., and R. W. Sauerwein. 2010. Interferon-γ: central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria. J. Leukoc. Biol. 88: 1131-1143.
5. + T cell-dependent, interferon-γ-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J. Exp. Med. 184: 597-607.
6. Cua, D. J., and C. M. Tato. 2010. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 10: 479-489.
7. Leppkes, M., C. Becker, I. I. Ivanov, S. Hirth, S. Wirtz, C. Neufert, S. Pouly, A. J. Murphy, D. M. Valenzuela, G. D. Yancopoulos, et al. 2009. RORγ-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 136: 257-267.
8. lo) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology. J. Exp. Med. 208: 1027-1040.
9. Aujla, S. J., Y. R. Chan, M. Zheng, M. Fei, D. J. Askew, D. A. Pociask, T. A. Reinhart, F. McAllister, J. Edeal, K. Gaus, et al. 2008. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14: 275-281. (Pubitemid 351347908)
10. + lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34: 122-134.
11. Zheng, Y., P. A. Valdez, D. M. Danilenko, Y. Hu, S. M. Sa, Q. Gong, A. R. Abbas, Z. Modrusan, N. Ghilardi, F. J. de Sauvage, and W. Ouyang. 2008. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14: 282-289. (Pubitemid 351347912)
12. Ivanov, I. I., B. S. McKenzie, L. Zhou, C. E. Tadokoro, A. Lepelley, J. J. Lafaille, D. J. Cua, and D. R. Littman. 2006. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133. (Pubitemid 44380299)
13. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189. (Pubitemid 43214587)
14. H-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8: 967-974.
15. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132.
16. Cruz, A., S. A. Khader, E. Torrado, A. Fraga, J. E. Pearl, J. Pedrosa, A. M. Cooper, and A. G. Castro. 2006. Cutting edge: IFN-γ regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J. Immunol. 177: 1416-1420. (Pubitemid 44092473)
17. H17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt. Nat. Immunol. 12: 96-104.
18. Owen, D. 1975. Eimeria falciformis (Eimer, 1870) in specific pathogen free and gnotobiotic mice. Parasitology 71: 293-303.
19. Shirley, M. W., A. Ivens, A. Gruber, A. M. Madeira, K. L. Wan, P. H. Dear, and F. M. Tomley. 2004. The Eimeria genome projects: a sequence of events. Trends Parasitol. 20: 199-201. (Pubitemid 38510311)
20. Kurth, M., and R. Entzeroth. 2008. Improved excystation protocol for Eimeria nieschulzi (Apikomplexa, Coccidia). Parasitol. Res. 102: 819-822.
21. + T cells during mycobacterial infection to promote apoptosis by inducing components of the intracellular apoptosis machinery and by inducing extracellular proapoptotic signals. J. Immunol. 179: 939-949.
22. Andoh, A., Z. Zhang, O. Inatomi, S. Fujino, Y. Deguchi, Y. Araki, T. Tsujikawa, K. Kitoh, S. Kim-Mitsuyama, A. Takayanagi, et al. 2005. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129: 969-984. (Pubitemid 41242688)
23. Pickert, G., C. Neufert, M. Leppkes, Y. Zheng, N. Wittkopf, M. Warntjen, H.-A. Lehr, S. Hirth, B. Weigmann, S. Wirtz, et al. 2009. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J. Exp. Med. 206: 1465-1472.
24. Buonocore, S., P. P. Ahern, H. H. Uhlig, I. I. Ivanov, D. R. Littman, K. J. Maloy, and F. Powrie. 2010. Innate lymphoid cells drive interleukin-23- dependent innate intestinal pathology. Nature 464: 1371-1375.
25. Codarri, L., G. Gyülvészi, V. Tosevski, L. Hesske, A. Fontana, L. Magnenat, T. Suter, and B. Becher. 2011. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12: 560-567.
26. Castaneda, F. E., B. Walia, M. Vijay-Kumar, N. R. Patel, S. Roser, V. L. Kolachala, M. Rojas, L. Wang, G. Oprea, P. Garg, et al. 2005. Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP. Gastroenterology 129: 1991-2008. (Pubitemid 41772976)
27. Muñoz, M., M. M. Heimesaat, K. Danker, D. Struck, U. Lohmann, R. Plickert, S. Bereswill, A. Fischer, I. R. Dunay, K. Wolk, et al. 2009. Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J. Exp. Med. 206: 3047-3059.
28. Morrison, P. J., S. J. Ballantyne, and M. C. Kullberg. 2011. Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity. Immunology 133: 397-408.
29. Duerr, R. H., K. D. Taylor, S. R. Brant, J. D. Rioux, M. S. Silverberg, M. J. Daly, A. H. Steinhart, C. Abraham, M. Regueiro, A. Griffiths, et al. 2006. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461-1463. (Pubitemid 44871953)
30. + T cells restrain the development of experimental allergic encephalomyelitis by suppressing Th17. Am. J. Pathol. 176: 2764-2775.
31. Desvignes, L., and J. D. Ernst. 2009. Interferon-γ-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity 31: 974-985.
32. Kelchtermans, H., E. Schurgers, L. Geboes, T. Mitera, J. Van Damme, J. Van Snick, C. Uyttenhove, and P. Matthys. 2009. Effector mechanisms of interleukin-17 in collagen-induced arthritis in the absence of interferon-γ and counteraction by interferon-γ. Arthritis Res. Ther. 11: R122.
33. He, D., H. Li, N. Yusuf, C. A. Elmets, J. Li, J. D. Mountz, and H. Xu. 2010. IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells. J. Immunol. 184: 2281-2288.
34. Liu, L., S. Okada, X.-F. Kong, A. Y. Kreins, S. Cypowyj, A. Abhyankar, J. Toubiana, Y. Itan, M. Audry, P. Nitschke, et al. 2011. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 208: 1635-1648.
35. Savan, R., S. Ravichandran, J. R. Collins, M. Sakai, and H. A. Young. 2009. Structural conservation of interferon gamma among vertebrates. Cytokine Growth Factor Rev. 20: 115-124.
36. Rose, M. E., D. Wakelin, and P. Hesketh. 1991. Interferon-γ- mediated effects upon immunity to coccidial infections in the mouse. Parasite Immunol. 13: 63-74.
37. Conti, H. R., F. Shen, N. Nayyar, E. Stocum, J. N. Sun, M. J. Lindemann, A. W. Ho, J. H. Hai, J. J. Yu, J. W. Jung, et al. 2009. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 206: 299-311.
38. De Luca, A., T. Zelante, C. D'Angelo, S. Zagarella, F. Fallarino, A. Spreca, R. G. Iannitti, P. Bonifazi, J.-C. Renauld, F. Bistoni, et al. 2010. IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol. 3: 361-373.
39. Pitta, M. G. R., A. Romano, S. Cabantous, S. Henri, A. Hammad, B. Kouriba, L. Argiro, M. el Kheir, B. Bucheton, C. Mary, et al. 2009. IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani. J. Clin. Invest. 119: 2379-2387.
40. Miyazaki, Y., S. Hamano, S. Wang, Y. Shimanoe, Y. Iwakura, and H. Yoshida. 2010. IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection. J. Immunol. 185: 1150-1157.
41. Sonnenberg, G. F., L. A. Fouser, and D. Artis. 2011. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 12: 383-390.